Clinical Trials Logo

VIN2 clinical trials

View clinical trials related to VIN2.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03180684 Completed - Clinical trials for Human Papillomavirus (HPV)

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Start date: August 31, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and efficacy of an investigational immunotherapy VGX-3100, in combination with a study device, to treat women with vulvar high-grade squamous intraepithelial lesion (HSIL) [vulval intraepithelial neoplasia 2 or 3 (VIN 2 or VIN 3)] associated with human papilloma virus (HPV) types 16 and/or 18. VGX-3100 is being assessed as an alternative to surgery with the potential to clear the underlying HPV infection. For more information visit our study website at: www.VINresearchstudy.com